Daylight-mediated photodynamic therapy of basal cell carcinomas - An explorative study

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 2, 2014, Pages 169-175

  Wiegell, S R ^a   Skodt V ^a   Wulf, H C ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; SUNSCREEN; AMINOLEVULINIC ACID; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT;

ADULT; ARTICLE; BASAL CELL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SUNLIGHT; YOUNG ADULT; ADVERSE EFFECTS; AGED; ANALOGS AND DERIVATIVES; BACK; CARCINOMA, BASAL CELL; FACIAL NEOPLASMS; LEG; MIDDLE AGED; PHOTOCHEMOTHERAPY; PROCEDURES; RADIOMETRY; SCALP; SKIN NEOPLASMS; THORAX; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; BACK; CARCINOMA, BASAL CELL; FACIAL NEOPLASMS; FEMALE; HUMANS; LEG; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROSPECTIVE STUDIES; RADIOMETRY; SCALP; SKIN NEOPLASMS; SUNLIGHT; THORAX; TREATMENT OUTCOME;

EID: 84892591809     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12076     Document Type: Article

References (17)

1. Roewert-Huber J, Lange-Asschenfeldt B, Stockfleth E, Kerl H,. Epidemiology and aetiology of basal cell carcinoma. Br J Dermatol 2007; 157: s47-s51.
2. Telfer NR, Colver GB, Morton CA, British Association of Dermatologists. Guidelines for the management of basal cell carcinoma. Br J Dermatol 2008; 159: 35-48.
3. Kennedy JC, Pottier RH,. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol, B 1992; 14: 275-292.
4. Angell-Petersen E, Sørensen R, Warloe T, et al,. Porphyrin formation in actinic keratoses and basal cell carcinoma after topical application of methyl 5-aminolevulinate. J Invest Dermatol 2006; 126: 265-271.
5. Wiegell SR, Haedersdal M, Philipsen PA, Eriksen P, Enk CD, Wulf HC,. Continuous activation of PplX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses-a randomized, controlled, single-blinded study. Br J Dermatol 2008; 158: 740-746.
6. Wiegell SR, Hædersdal M, Eriksen P, Wulf HC,. Photodynamic therapy of actinic keratoses with 8% and 16% methyl aminolevulinate and home-based daylight exposure: a double-blinded randomized clinical trial. Br J Dermatol 2009; 160: 1308-1314.
7. Wiegell SR, Fabricius S, Stender IM, et al,. A randomized, multicentre study of directed daylight exposure times of 1 vs. 2 h in daylight-mediated photodynamic therapy with methyl aminolevulinate in patients with multiple thin actinic keratoses of the face and scalp. Br J Dermatol 2011; 164: 1083-1090.
8. Wiegell SR, Fabricius S, Gniadecka M, et al,. Daylight-mediated photodynamic therapy of moderate to thick actinic keratoses of the face and scalp: a randomized multicentre study. Br J Dermatol 2012; 166: 1327-1332.
9. Heydenreich J, Wulf HC,. Miniature personal electronic UVR dosimeter with erythema response and time-stamped readings in a wristwatch. Photochem Photobiol 2005; 81: 1138-1144.
10. Szeimies RM, Ibbotson S, Murrell DF, et al,., Excilight Study Group. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol 2008; 22: 1302-1311.
11. Rhodes LE, de Rie M, Enström Y, et al,. Photodynamic therapy using topical methyl aminolevulinate vs. surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol 2004; 140: 17-23.
12. Horn M, Wolf P, Wulf HC, et al,. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149: 1242-1249.
13. Basset-Seguin N, Ibbotson SH, Emtestam L, et al,. Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial. Eur J Dermatol 2008; 18: 547-553.
14. Wiegell SR, Wulf HC, Szeimies RM, et al,. Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology. J Eur Acad Dermatol Venereol 2012; 26: 673-679.
15. Wiegell SR, Fabricius S, Heydenreich J, et al,. Weather conditions and daylight-mediated photodynamic therapy-protoporphyrin IX weighted daylight doses measured in 6 geographic localisations. Br J Dermatol 2012; Aug 4. doi: 10.1111/j.1365-2133.2012.11200.x. [Epub ahead of print].
16. Grapengiesser S, Ericson M, Gudmundsson F, et al,. Pain caused by photodynamic therapy of skin cancer. Clin Exp Dermatol 2002; 27: 493-497.
17. Wang I, Bendsoe N, Klinteberg CA, et al,. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001; 144: 832-840.